Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-30 12:12 pm Purchase | 13D | UROVANT SCIENCES LTD SHS UROV | Sumitomo Chemical Co. Ltd. | 22,963,479 100% | 216 (+0.00%) | View |
| 2021-02-16 3:38 pm Purchase | 13G | UROVANT SCIENCES LTD SHS UROV | PERCEPTIVE ADVISORS LLC | 3,116,831 9.8% | 709,900 (+29.49%) | View |
| 2020-11-12 5:11 pm Purchase | 13D | UROVANT SCIENCES LTD SHS UROV | Sumitomo Chemical Co. Ltd. | 22,963,263 72.4% | 103,250 (+0.45%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | UROVANT SCIENCES LTD SHS UROV | PERCEPTIVE ADVISORS LLC | 2,406,931 7.9% | 808,654 (+50.60%) | View |
| 2020-01-06 08:40 am Purchase | 13D | UROVANT SCIENCES LTD SHS UROV | Sumitomo Chemical Co. Ltd. | 22,860,013 75.2% | 22,860,013 (New Position) | View |
| 2019-12-31 4:45 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 0 0% | -22,860,013 (Position Closed) | View |
| 2019-11-04 06:05 am Unchanged | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 22,860,013 75.4% | 0 (Unchanged) | View |
| 2019-09-06 5:06 pm Unchanged | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 22,860,013 75.4% | 0 (Unchanged) | View |
| 2019-07-16 5:41 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | Lo Andrew | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-07-16 5:31 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | Machado Patrick | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-07-16 5:30 pm Purchase | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 22,860,013 75.4% | 156,344 (+0.69%) | View |
| 2019-07-12 4:52 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | VIKING GLOBAL INVESTORS LP | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-07-12 4:49 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | Dexxon Holdings Ltd. | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-07-12 4:43 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | QVT Financial LP | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-07-12 4:32 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | SVF Investments (UK) Ltd | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-06-24 5:00 pm Purchase | 13G | UROVANT SCIENCES LTD SHS UROV | PERCEPTIVE ADVISORS LLC | 1,598,277 5.3% | 1,598,277 (New Position) | View |